Developer docs
API playgroundTry for free, no card

Search company profiles

Cellavision Ab Ord

Full company profile

uuid0028izq

Namestring
Cellavision Ab Ord
Legal namestring
CellaVision AB (publ)
Websiteurl
cellavision.com
Company typeenum
Public
Founded yearint
1994
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLund, Sweden
HQ citystring
Lund
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital cell morphology, hematology analyzers, medical laboratory automation, in vitro diagnostics, blood cell imaging
Industry4 codes
1Microscopy, Imaging & Flow Cytometry Instruments
CodeHLAGAIAEPrimaryYes
2Flow Cytometry & Cellular Analysis Diagnostics
CodeHLAHAAAFPrimaryNo
3Cell-Based & Potency Assays (Bioassays)
CodeHLAGADAHPrimaryNo
4Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
CodeHLAAALAOPrimaryNo
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Surgical and Medical Instrument Manufacturing339112
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
Product category
Digital Hematology Microscopy and Cell Morphology
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Hardware - Analyzers
TypeHardware Sales
Description

Sale of digital cell morphology analyzers including CellaVision DC-1, DM1200, and DM9600. Analyzer manufacturing is outsourced in Sweden. One-time hardware purchase model with ongoing software and reagent needs.

cellavision.com
2Software Licenses and Subscriptions
TypeSubscription Recurring
Description

Software applications including Peripheral Blood Application, Advanced RBC Application, Body Fluid Application, Bone Marrow Aspirate Application, Review Software, and Server Software. Likely subscription or perpetual license model with annual maintenance/support.

cellavision.com
3Reagents
TypeSubscription Recurring
Description

Stains and reagents for hematology including RAL Diagnostics branded products. Reagent manufacturing performed in-house at Bordeaux, France facility. Covers automated staining, manual staining, hematology, microbiology, cytology, and histology applications.

cellavision.com
4Training and Certification Services
TypeProfessional Services
Description

CellaVision Academy provides certification programs for service engineers and applications specialists. Includes self-paced e-learning, instructor-led courses, and 'Ask the Expert' monthly sessions. Free for distribution partners.

cellavision.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1RAL Diagnostics
Description

Stains and reagents brand for hematology diagnostics, including RAL Stainer and RAL StainBox products

cellavision.com
+3 more records
Core offering1 text field

CellaVision develops and sells digital cell morphology systems for routine analysis of blood and other body fluids in hematology laboratories. Its offering combines digital microscopy analyzers, AI-powered software applications for cell pre-classification, staining instruments, and reagents, replacing traditional manual microscopy with automated workflows for peripheral blood, bone marrow aspirate, red blood cells, and body fluid analysis. The company serves hospital laboratories, reference laboratories, and veterinary labs globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Processes up to 45 slides per hour with Software 7.2 (DI-60 with serial number 70000+)
+4 more records
Product overview1 text field

CellaVision offers a unified platform-plus-modules architecture for digital hematology microscopy. The core consists of hardware analyzers (DC-1, DM1200, DM9600) and the Digital Cell Morphology Software that work together to automate blood cell morphology analysis. Software modules extend the platform: the Peripheral Blood Application handles routine differentials, the Advanced RBC Application analyzes red cells, the Body Fluid Application covers non-blood samples, and the Bone Marrow Aspirate Application (recently launched 2026) addresses complex bone marrow analysis. The Review Software and Server Software enable remote collaboration across laboratory networks. Supporting infrastructure includes RAL StainBox and RAL Stainer instruments, RAL Diagnostics reagents, and educational tools (CellAtlas, Proficiency Software). The Sysmex partnership extends market reach for the BMA Application. Over 9,500 analyzer units have been sold globally.

Product and service18 records
1CellaVision DC-1 Analyzer
CategoryHardware Analyzer
Description

Compact digital hematology analyzer that automatically scans and captures images of blood cell samples for digital morphology analysis. Supports both peripheral blood and bone marrow analysis on one integrated platform with genuine 100x magnification.

2CellaVision DM1200 Analyzer
CategoryHardware Analyzer
Description

Digital hematology analyzer for medium to large laboratories, supporting automated blood cell morphology analysis.

3CellaVision DM9600 Analyzer
4DIFF-Line by CellaVision
5RAL StainBox
6RAL Stainer
7CellaVision Bone Marrow Aspirate Application
CategorySoftware Application
Description

AI-powered digital workflow application for bone marrow morphology analysis. Automatically locates analysis areas, captures high-resolution images, and pre-classifies nucleated cells into 17 cell types. CE marked as Class C device under EU IVDR.

8CellaVision Peripheral Blood Application
9CellaVision Advanced RBC Application
10CellaVision Body Fluid Application
11CellaVision Review Software
12CellaVision Server Software
13CellaVision Scanner Application
14CellaVision VET
15CellaVision Digital Cell Morphology Software 7.2
CategorySoftware Platform
Description

Major software release featuring processing up to 45 slides per hour on DI-60 analyzers (serial number 70000+), new modern GUI, enhanced microscopy with cooler color balance, split view comparison tools for patient results, RBC analysis improvements, multi-user discussions and commenting, and Central QC review for DC-1 analyzers.

16RAL Diagnostics Reagents
17CellaVision Proficiency Software
18CellaVision CellAtlas
CategorySoftware Application
Description

Educational blood cell encyclopedia and morphology reference tool featuring comprehensive cell images, interactive hematopoiesis flowchart, and blood cell quizzes. Available as web application and mobile app.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-13
Description

Sysmex is the distribution partner for the CellaVision Bone Marrow Aspirate (BMA) Application across the EMEA region. Sysmex holds the highest global market share in the large hematology segment, providing broad market reach and established relationships with hospital and reference laboratories. The partnership leverages Sysmex's distribution network for the BMA product launch in Europe.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Manufacturer of hematology analyzers (ABX / Yumizen lines) and a direct competitor to CellaVision in mid- and large-volume hematology laboratories globally, particularly in European and emerging markets.

TypeDirect peer
Description

Global leader in hematology and hemostasis analyzers and CellaVision's exclusive EMEA distribution partner for the Bone Marrow Aspirate Application. Both companies target hematology laboratories and increasingly compete/collaborate in digital cell morphology workflows.

TypeBroad incumbent
Description

Global IVD incumbent with hematology and digital diagnostics products (cobas line) sold into hospital and reference laboratories. Represents both a competitive threat via integrated workflows and a potential partnership/benchmark for CellaVision's AI diagnostics.

TypeEmerging player
Description

Israeli digital cell morphology startup applying AI and full-field imaging to peripheral blood and bone marrow analysis. Direct emerging competitor to CellaVision's core digital morphology platform and a potential disruptor to its installed base.

TypeBroad incumbent
Description

Through its CytoVision product line, Hologic offers digital chromosome and cytogenetics imaging systems used in hematology/cancer diagnostics workflows — adjacent but comparable digital microscopy applications serving similar clinical laboratory customers.

TypeEmerging player
Description

Chinese medical device company rapidly expanding in hematology analyzers and laboratory automation, competing on price-performance in emerging markets where CellaVision also seeks growth (China, India, Brazil).

TypeRegional player
Description

Japanese medical device company with strong presence in hematology analyzers across APAC, particularly Japan, and serves the same regional customer base as CellaVision's APAC commercial footprint.

TypeBroad incumbent
Description

Broad diagnostics portfolio including hematology analyzers (Atellica / ADVIA lines) and laboratory automation sold to the same large hospital and reference laboratory customers CellaVision serves, often as part of integrated chemistry/immunoassay/hematology bids.

TypeBroad incumbent
Description

Multi-modality diagnostics company with hematology and core laboratory solutions serving large hospital networks and reference labs — the same enterprise buyer CellaVision targets with its digital morphology platform.

TypeBroad incumbent
Description

Major hematology analyzer manufacturer under Danaher's diagnostics platform, offering integrated cell analysis and laboratory automation workflows to large hospital and reference lab customers that overlap with CellaVision's enterprise target market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cellavision Ab Ord

Digital Hematology Microscopy and Cell Morphologycellavision.com

Cellavision Ab Ord firmographics

Firmographics
Name
Cellavision Ab Ord
Legal name
CellaVision AB (publ)
Website
https://cellavision.com
Company type
Public
Founded year
1994
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Cellavision Ab Ord industry classification

Industry
Product category
Digital Hematology Microscopy and Cell Morphology
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Surgical and Medical Instrument Manufacturing (339112)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
akta.pro secondary industries
Flow Cytometry & Cellular Analysis Diagnostics (HLAHAAAF), Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

Keywords

  • Digital cell morphology
  • Hematology analyzers
  • Medical laboratory automation
  • In vitro diagnostics
  • Blood cell imaging

Where Cellavision Ab Ord is headquartered

Location

Headquarters

HQ city
Lund
HQ country
Sweden
HQ region
Europe

Offices4 records

Markets served

Cellavision Ab Ord business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Hardware - Analyzers: Sale of digital cell morphology analyzers including CellaVision DC-1, DM1200, and DM9600. Analyzer manufacturing is outsourced in Sweden. One-time hardware purchase model with ongoing software and reagent needs.
  2. Software Licenses and Subscriptions: Software applications including Peripheral Blood Application, Advanced RBC Application, Body Fluid Application, Bone Marrow Aspirate Application, Review Software, and Server Software. Likely subscription or perpetual license model with annual maintenance/support.
  3. Reagents: Stains and reagents for hematology including RAL Diagnostics branded products. Reagent manufacturing performed in-house at Bordeaux, France facility. Covers automated staining, manual staining, hematology, microbiology, cytology, and histology applications.
  4. Training and Certification Services: CellaVision Academy provides certification programs for service engineers and applications specialists. Includes self-paced e-learning, instructor-led courses, and 'Ask the Expert' monthly sessions. Free for distribution partners.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Cellavision Ab Ord product offering

Product offering

Core offering

CellaVision develops and sells digital cell morphology systems for routine analysis of blood and other body fluids in hematology laboratories. Its offering combines digital microscopy analyzers, AI-powered software applications for cell pre-classification, staining instruments, and reagents, replacing traditional manual microscopy with automated workflows for peripheral blood, bone marrow aspirate, red blood cells, and body fluid analysis. The company serves hospital laboratories, reference laboratories, and veterinary labs globally.

Product overview

CellaVision offers a unified platform-plus-modules architecture for digital hematology microscopy. The core consists of hardware analyzers (DC-1, DM1200, DM9600) and the Digital Cell Morphology Software that work together to automate blood cell morphology analysis. Software modules extend the platform: the Peripheral Blood Application handles routine differentials, the Advanced RBC Application analyzes red cells, the Body Fluid Application covers non-blood samples, and the Bone Marrow Aspirate Application (recently launched 2026) addresses complex bone marrow analysis. The Review Software and Server Software enable remote collaboration across laboratory networks. Supporting infrastructure includes RAL StainBox and RAL Stainer instruments, RAL Diagnostics reagents, and educational tools (CellAtlas, Proficiency Software). The Sysmex partnership extends market reach for the BMA Application. Over 9,500 analyzer units have been sold globally.

Differentiator

Problem solved

Functional benefit

Brands

  • RAL Diagnostics: Stains and reagents brand for hematology diagnostics, including RAL Stainer and RAL StainBox products
  • DIFF-Line
  • CellAtlas
  • CellaVision Proficiency Software

Products and services

  • CellaVision DC-1 Analyzer Compact digital hematology analyzer that automatically scans and captures images of blood cell samples for digital morphology analysis. Supports both peripheral blood and bone marrow analysis on one integrated platform with genuine 100x magnification.
  • CellaVision DM1200 Analyzer Digital hematology analyzer for medium to large laboratories, supporting automated blood cell morphology analysis.
  • CellaVision DM9600 Analyzer
  • DIFF-Line by CellaVision
  • RAL StainBox
  • RAL Stainer
  • CellaVision Bone Marrow Aspirate Application AI-powered digital workflow application for bone marrow morphology analysis. Automatically locates analysis areas, captures high-resolution images, and pre-classifies nucleated cells into 17 cell types. CE marked as Class C device under EU IVDR.
  • CellaVision Peripheral Blood Application
  • CellaVision Advanced RBC Application
  • CellaVision Body Fluid Application
  • CellaVision Review Software
  • CellaVision Server Software
  • CellaVision Scanner Application
  • CellaVision VET
  • CellaVision Digital Cell Morphology Software 7.2 Major software release featuring processing up to 45 slides per hour on DI-60 analyzers (serial number 70000+), new modern GUI, enhanced microscopy with cooler color balance, split view comparison tools for patient results, RBC analysis improvements, multi-user discussions and commenting, and Central QC review for DC-1 analyzers.
  • RAL Diagnostics Reagents
  • CellaVision Proficiency Software
  • CellaVision CellAtlas Educational blood cell encyclopedia and morphology reference tool featuring comprehensive cell images, interactive hematopoiesis flowchart, and blood cell quizzes. Available as web application and mobile app.

Quantifiable outcome

  • Processes up to 45 slides per hour with Software 7.2 (DI-60 with serial number 70000+)
  • +4 more outcomes

Companies that use Cellavision Ab Ord

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Cellavision Ab Ord technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature7 records

Cellavision Ab Ord partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sysmex CorporationcoreChannel Partner/ Reseller/ Distributor · 13 March 2026Sysmex is the distribution partner for the CellaVision Bone Marrow Aspirate (BMA) Application across the EMEA region. Sysmex holds the highest global market share in the large hematology segment, providing broad market reach and established relationships with hospital and reference laboratories. The partnership leverages Sysmex's distribution network for the BMA product launch in Europe.

Scale indicators13 records

Recent moves8 records

Expansion highlights5 records

Cellavision Ab Ord competitors and assessment

Company assessment

Direct peers

  • HORIBA Medical: Manufacturer of hematology analyzers (ABX / Yumizen lines) and a direct competitor to CellaVision in mid- and large-volume hematology laboratories globally, particularly in European and emerging markets.
  • Sysmex Corporation: Global leader in hematology and hemostasis analyzers and CellaVision's exclusive EMEA distribution partner for the Bone Marrow Aspirate Application. Both companies target hematology laboratories and increasingly compete/collaborate in digital cell morphology workflows.

Broad incumbents

  • Roche Diagnostics: Global IVD incumbent with hematology and digital diagnostics products (cobas line) sold into hospital and reference laboratories. Represents both a competitive threat via integrated workflows and a potential partnership/benchmark for CellaVision's AI diagnostics.
  • Hologic (CytoVision): Through its CytoVision product line, Hologic offers digital chromosome and cytogenetics imaging systems used in hematology/cancer diagnostics workflows — adjacent but comparable digital microscopy applications serving similar clinical laboratory customers.
  • Siemens Healthineers: Broad diagnostics portfolio including hematology analyzers (Atellica / ADVIA lines) and laboratory automation sold to the same large hospital and reference laboratory customers CellaVision serves, often as part of integrated chemistry/immunoassay/hematology bids.
  • Abbott Diagnostics: Multi-modality diagnostics company with hematology and core laboratory solutions serving large hospital networks and reference labs — the same enterprise buyer CellaVision targets with its digital morphology platform.
  • Beckman Coulter (Danaher): Major hematology analyzer manufacturer under Danaher's diagnostics platform, offering integrated cell analysis and laboratory automation workflows to large hospital and reference lab customers that overlap with CellaVision's enterprise target market.

Emerging players

  • Scopio Labs: Israeli digital cell morphology startup applying AI and full-field imaging to peripheral blood and bone marrow analysis. Direct emerging competitor to CellaVision's core digital morphology platform and a potential disruptor to its installed base.
  • Mindray Bio-Medical: Chinese medical device company rapidly expanding in hematology analyzers and laboratory automation, competing on price-performance in emerging markets where CellaVision also seeks growth (China, India, Brazil).

Regional players

  • Nihon Kohden: Japanese medical device company with strong presence in hematology analyzers across APAC, particularly Japan, and serves the same regional customer base as CellaVision's APAC commercial footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cellavision Ab Ord social profiles

Digital presence

Cellavision Ab Ord compliance and trust

Trust signal

Compliance1 record

Cellavision Ab Ord financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cellavision Ab Ord leadership team

Management profile

Number of profiles

Profiles8 records

Cellavision Ab Ord subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cellavision Ab Ord funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cellavision Ab Ord M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cellavision Ab Ord

What does Cellavision Ab Ord do?

CellaVision develops and sells digital cell morphology systems for routine analysis of blood and other body fluids in hematology laboratories. Its offering combines digital microscopy analyzers, AI-powered software applications for cell pre-classification, staining instruments, and reagents, replacing traditional manual microscopy with automated workflows for peripheral blood, bone marrow aspirate, red blood cells, and body fluid analysis. The company serves hospital laboratories, reference laboratories, and veterinary labs globally.

Is Cellavision Ab Ord a public or private company?

Cellavision Ab Ord is a public company. It is classified as public and is currently operating.

When was Cellavision Ab Ord founded?

Cellavision Ab Ord was founded in 1994. It employs 101 to 250 people.

Where is Cellavision Ab Ord based?

Cellavision Ab Ord is headquartered in Lund, Sweden, in the Europe region.

How does Cellavision Ab Ord make money?

Four revenue lines are on record. Hardware - Analyzers are the primary driver. The others are software Licenses and Subscriptions, reagents and training and Certification Services.

Who are Cellavision Ab Ord's main competitors?

Direct peers on record are HORIBA Medical and Sysmex Corporation. Broad incumbents are Roche Diagnostics, Hologic (CytoVision), Siemens Healthineers, Abbott Diagnostics and Beckman Coulter (Danaher). Emerging players are Scopio Labs and Mindray Bio-Medical. Nihon Kohden is listed as a regional player.

Does Cellavision Ab Ord have an API?

No public API is recorded for Cellavision Ab Ord.

What industry is Cellavision Ab Ord in?

Cellavision Ab Ord's product category is Digital Hematology Microscopy and Cell Morphology. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAHAAAF, Flow Cytometry & Cellular Analysis Diagnostics. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comEarnings call transcript: CellaVision Q2 2026 sales rise as Americas hit record By Investing.comCellaVision AB reported Q2 2026 sales of SEK 200 million, a 4.5% increase year-over-year, with the Americas delivering record sales of SEK 105 million, up 59% from the prior year. The Swedish microscopy company also launched its bone marrow aspirate application in EMEA, generating initial sales with management maintaining guidance that it could add 1% to 2% to total sales by year-end, pending U.S. FDA 510(k) clearance. The company noted strong order books heading into H2 2026 and completed a distributor inventory adjustment in EMEA that had weighed on earlier periods.GlobeNewswireCellaVision AB: Good profitability despite negative COVID-19-effectCellaVision reported Q2 2020 net sales of SEK 118.0 million, down 15% organically, with EBITDA margin at 31%. The company expects COVID-19 to negatively affect sales and earnings for months, and CEO Zlatko Rihter will leave by November 28, 2020.GlobeNewswireCellaVision AB presents the second quarter for 2020CellaVision AB will publish its Q2 2020 interim report on July 16, 2020, with a conference call at 11:00 CET. The report is available on the company's website, and CEO Zlatko Rihter will present. 2019 sales were SEK 462 million, with a 15% annual growth target.GlobeNewswireCellaVision AB: Zlatko Rihter leaves his position as CEO at CellaVision ABZlatko Rihter resigned as CEO of CellaVision AB to become CEO of Mölnlycke Health Care, effective November 28, 2020. He had led the company since 2015, during which sales and earnings nearly tripled. The board initiated a recruitment process for his successor.GlobeNewswireCellaVision AB: CellaVisions Annual report for 2019 is now availableCellaVision AB made its 2019 annual report available as a PDF on May 26, 2020, and printed a limited number of copies per its environmental policy. The company reported 2019 sales of SEK 462 million and a growth target of 15% per year over an economic cycle.GlobeNewswireCellaVision AB: Notice of the Annual General Meeting 2020CellaVision AB held its 2020 Annual General Meeting on June 16, 2020, with shareholders summoned to attend. The board proposed no dividend for 2019 and set senior management remuneration guidelines, including a long-term cash-based incentive program. Shareholders may vote by proxy, with registration due by June 10.GlobeNewswireCellaVision AB: Stable start of the year with good growth in APACCellaVision reported Q1 2020 net sales of SEK 134.4 million, up 29% year-over-year, with EBITDA margin at 31%. The company postponed its AGM and withdrew the 2019 dividend due to COVID-19's expected negative impact on sales and earnings.GlobeNewswireCellaVision AB presents the first quarter for 2020 on April 22, at 11:00 CETCellaVision AB will publish its first-quarter 2020 interim report on April 22, 2020, at 8:20 CET, with a conference call at 11:00 CET. The report will be available on the company's website, and the call will be in English.GlobeNewswireCellaVision AB: Notice of 2020 Annual General Meeting of CellaVision (publ)CellaVision AB's 2020 AGM is scheduled for April 23, 2020, in Lund, Sweden, with shareholder registration by April 17. The board proposes a SEK 1.5 dividend per share and re-election of seven board members, including chairman Sören Mellstig. The notice also sets new senior management remuneration guidelines.GlobeNewswireCellaVision AB: Nomination Committee proposes re-electionCellaVision's Nomination Committee proposed re-election of Sören Mellstig as chairman and six other board members, plus election of Mikael Worning as a new member. The proposal was submitted to the Annual General Meeting on February 5, 2020, with the AGM scheduled for April 23 in Lund.